ArticleBreast cancer research and treatment2022

False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy.

Jana de Boniface et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.